Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond inhibition: harnessing the DRD2-VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer.

Frontiers in oncology·2026

Same author

Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Same author

Angiotensin II type 1 receptor blockade inhibits gastric cancer metastasis through tight junction restoration.

Cancer letters·2026

Same author

Ultrasound-Mediated Nanocarrier-Based Drug Delivery in Breast Cancer Therapy: Innovations and Outlook.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2025

Same author

Design, development, and evaluation of magnetic nanoparticles and docetaxel-loaded nanosystem for brain targeting.

Therapeutic delivery·2025

Same author

Design, synthesis, anti-breast cancer and <i>in silico</i> studies of substituted triphenyl imidazole-<i>N-</i>alkyl linked indole derivatives.

Future medicinal chemistry·2025

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Catecholamines regulate tumor angiogenesis.

Debanjan Chakroborty¹, Chandrani Sarkar, Biswarup Basu

¹Department of Pathology, Ohio State University, Columbus, Ohio 43210, USA.

Cancer Research

|April 23, 2009

Summary

Catecholamine neurotransmitters have opposing roles in tumor angiogenesis. Norepinephrine and epinephrine promote tumor growth, while dopamine inhibits it by suppressing vascular endothelial growth factor-A.

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Related Experiment Videos

Last Updated: Jun 23, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Area of Science:

Oncology
Neuroscience
Pharmacology

Background:

Tumor angiogenesis is crucial for cancer growth and metastasis.
Catecholamines, including norepinephrine, epinephrine, and dopamine, are neurotransmitters with potential roles in regulating angiogenesis.
Understanding these roles can lead to novel cancer therapies.

Purpose of the Study:

To investigate the distinct roles of catecholamine neurotransmitters in regulating tumor neovascularization.
To explore the potential of targeting catecholamine pathways for cancer treatment.

Main Methods:

The study examines the effects of norepinephrine, epinephrine, and dopamine on tumor angiogenesis.
Specific adrenoceptors and D(2) receptors were investigated as mediators of these effects.
The impact on proangiogenic factors and vascular endothelial growth factor-A (VEGF-A) was assessed.

Main Results:

Norepinephrine and epinephrine, acting via adrenoceptors, enhance proangiogenic factor synthesis, promoting tumor growth.
Dopamine, via D(2) receptors, inhibits tumor growth by suppressing VEGF-A.
This suppression affects both tumor endothelial cells and bone marrow-derived endothelial progenitor cells.

Conclusions:

Catecholamine neurotransmitters are novel endogenous regulators of tumor angiogenesis with opposing functions.
Dopamine's inhibitory effect on tumor growth suggests potential as an inexpensive antiangiogenic therapeutic strategy.
Targeting catecholamine pathways offers a new avenue for cancer treatment.